Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema
Rohit Varma,1 Neil M Bressler,2 Quan V Doan,3 Ivan J Suñer,4 Mark Danese,3 Chantal M Dolan,5 Abraham Lee,3 Jason S Ehrlich,5 Yamina Rajput5 1Southern California Eye Institute, CHA Hollywood Presbyterian Medical Center, Los Angeles, CA, USA; 2Johns Hopkins University, Baltimore, MD, USA; 3...
Guardado en:
Autores principales: | Varma R, Bressler NM, Doan QV, Suñer IJ, Danese M, Dolan CM, Lee A, Ehrlich JS, Rajput Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f403306b03b469cb754e3027fb841d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
por: Kartasasmita A, et al.
Publicado: (2019) -
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas BJ, et al.
Publicado: (2016) -
Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
por: Singer M, et al.
Publicado: (2020) -
Macular oedema as manifestation of diabetic retinopathy
por: Mukharram M. Bikbov, et al.
Publicado: (2017) -
Primary treatment of diabetic macular edema
por: Tushar M Ranchod, et al.
Publicado: (2009)